BOOST Pharma selected to showcase Phase III-ready BT-101 at 2026 Cell & Gene Meeting on the MesaSep 24, 2026 | EVENTS, PRESS RELEASE
Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong KongOct 31, 2025 | EVENTS, PRESS RELEASE